Development and evaluation of a simple treatment eligibility score
(HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study,
Lien de l'article:
https://pubmed.ncbi.nlm.nih.gov/38367633/
Auteur(s):
Minier N, Guingané NA, Okeke E, Sinkala E, Johannessen A, Andersson M I, Davwar P, Desalegn H, Duguru M, Fall F, Mboup S, Maponga T, Matthews P C, Mena A R, Ndow G, Orlien S.M.S, Riches N, Seydi M, Sonderup M, Spearman C W, Stockdale A J, Taljaard J, Vinikoor M, Wandeler G, Lemoine M, Shimakawa Y, Sombié R.
Auteur(s) tagués:
Nanelin Alice GUINGANE ;
Résumé
Background Hepatitis B virus (HBV) elimination requires expanding and decentralising HBV care services. However peripheral health facilities lack access to diagnostic tools to assess eligibility for antiviral therapy. Through the Hepatitis B in Africa Collaborative Network (HEPSANET), we aimed to develop and evaluate a score using tests generally available at lower-level facilities, to simplify the evaluation of antiviral therapy eligibility in people living with HBV.
Mots-clés